Cascade Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-325
Closed -$294K 115
2024
Q2
$294K Sell
325
-35
-10% -$28K 0.2% 101
2024
Q1
$280K Sell
360
-27
-7% -$19.2K 0.18% 102
2023
Q4
$226K Hold
387
0.16% 104
2023
Q3
$208K Buy
+387
New +$199K 0.16% 104
2023
Q2
Sell
-425
Closed -$146K 166
2023
Q1
$146K Buy
+425
New +$143K 0.12% 112
2022
Q3
Sell
-425
Closed -$138K 165
2022
Q2
$138K Hold
425
0.11% 118
2022
Q1
$122K Buy
425
+25
+6% +$6.43K 0.07% 130
2021
Q4
$110K Hold
400
0.06% 133
2021
Q3
$92.4K Hold
400
0.06% 133
2021
Q2
$91.8K Hold
400
0.06% 131
2021
Q1
$74.7K Hold
400
0.05% 139
2020
Q4
$67.5K Hold
400
0.05% 144
2020
Q3
$59.2K Hold
400
0.05% 141
2020
Q2
$65.7K Hold
400
0.06% 131
2020
Q1
$55.5K Hold
400
0.06% 133
2019
Q4
$52.6K Hold
400
0.04% 149
2019
Q3
$44.7K Hold
400
0.03% 155
2019
Q2
$44.3K Hold
400
0.04% 148
2019
Q1
$51.9K Hold
400
0.05% 132
2018
Q4
$46.3K Hold
400
0.05% 130
2018
Q3
$42.9K Hold
400
0.04% 135
2018
Q2
$34.1K Buy
+400
New +$32.9K 0.03% 143

Other funds holding LLY

Cascade Investment Advisors's LLY Position: Q3 2024 in Review

Cascade Investment Advisors sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 325 shares — an estimated $294K sold.

Cascade Investment Advisors first reported a position in LLY in Q2 2018 and held it in 22 quarters. The position peaked at $294K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Cascade Investment Advisors reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • Cascade Investment Advisors sold 325 Eli Lilly shares in Q3 2024, an estimated $294K.
  • Cascade Investment Advisors first reported a position in Eli Lilly in Q2 2018 and held it in 22 quarters.
  • Cascade Investment Advisors's Eli Lilly position peaked at $294K in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Cascade Investment Advisors's 13F filing for Q3 2024, filed 2 Oct 2024.